ALK
ALK inhibitors are compounds that specifically target and inhibit Anaplastic Lymphoma Kinase (ALK), a receptor tyrosine kinase involved in the development and progression of certain cancers, including non-small cell lung cancer and neuroblastoma. By inhibiting ALK, these compounds block signaling pathways that promote tumor cell growth and survival. At CymitQuimica, we offer ALK inhibitors to support your research in oncology, targeted cancer therapies, and signal transduction.
Read more
OD36 hydrochloride
CAS:2387510-88-3
OD36 hydrochloride (OD-36 hydrochloride) is a potent RIPK2 inhibitor with an IC50 of 5.3 nM.OD36 …
Formula:
C16H16Cl2N4O2
Purity:
99.85%
Color and Shape:
Liquid
Molecular weight:
367.23
Ref: TM-T61424
| 25mg | 1,197.00 € | ||
| 50mg | 1,561.00 € | ||
| 100mg | 2,320.00 € |
Estimated delivery in United States, on Friday 24 Jan 2025
EML4-ALK kinase inhibitor 1
CAS:1373409-08-5
Potent oral EML4-ALK inhibitor with a 1 nM IC50.
Formula:
C31H48N8O3
Purity:
99.14%
Color and Shape:
Solid
Molecular weight:
580.76
Ref: TM-T11184
| 1mg | 95.00 € | ||
| 5mg | 208.00 € | ||
| 10mg | 310.00 € | ||
| 25mg | 500.00 € | ||
| 50mg | 682.00 € | ||
| 100mg | 922.00 € | ||
| 500mg | 1,833.00 € | ||
| 1mL*10mM (DMSO) | 269.00 € |
Estimated delivery in United States, on Friday 24 Jan 2025
TGFBR1-IN-1
CAS:2170830-26-7
TGFBR1-IN-1 is an inhibitor of ALK5 (IC50 of 10-100 nM).
Formula:
C23H17N5O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
427.48
Ref: TM-T13138
| 25mg | 1,410.00 € | ||
| 50mg | 1,845.00 € | ||
| 100mg | 2,329.00 € |
Estimated delivery in United States, on Friday 24 Jan 2025
KER047
CAS:2248154-85-8
ALK2-IN-4, a highly effective ALK2 inhibitor.
Formula:
C26H30FN7O
Purity:
100% - 98.49%
Color and Shape:
Liquid
Molecular weight:
475.56
Ref: TM-T39764
| 1mg | 94.00 € | ||
| 5mg | 223.00 € | ||
| 10mg | 362.00 € | ||
| 25mg | 739.00 € | ||
| 50mg | 1,053.00 € | ||
| 100mg | 1,613.00 € | ||
| 1mL*10mM (DMSO) | 246.00 € |
Estimated delivery in United States, on Friday 7 Feb 2025
IN-1130
CAS:868612-83-3
IN-1130: ALK5 inhibitor, IC50 - 5.3 nM (Smad3), 36 nM (casein), 4.3 μM (p38α MAPK).
Formula:
C25H20N6O
Purity:
98.08%
Color and Shape:
Solid
Molecular weight:
420.47
Ref: TM-T15572
| 5mg | 52.00 € | ||
| 10mg | 90.00 € | ||
| 25mg | 167.00 € | ||
| 50mg | 255.00 € | ||
| 100mg | 368.00 € | ||
| 1mL*10mM (DMSO) | 58.00 € |
Estimated delivery in United States, on Friday 7 Feb 2025
ALK-IN-27
CAS:2739866-40-9
Neladalkib (NVL-655) is an ALK inhibitor with antitumor activity for the study of non-small cell …
Formula:
C23H22ClFN6O
Color and Shape:
Liquid
Molecular weight:
452.91
Ref: TM-T83146
| 1mg | 54.00 € | ||
| 5mg | 120.00 € | ||
| 10mg | 186.00 € | ||
| 25mg | 342.00 € | ||
| 50mg | 520.00 € | ||
| 1mL*10mM (DMSO) | 144.00 € |
Estimated delivery in United States, on Friday 7 Feb 2025
(-)-Cevimeline hydrochloride hemihydrate
(-)-Cevimeline HCl hemihydrate, a muscarinic agonist, treats Sjogren's xerostomia. Quick absorption, species-dependent metabolism.
Formula:
C10H19ClNO1·5S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
244.78
Ref: TM-T13421
| 25mg | 3,673.00 € |
Estimated delivery in United States, on Friday 7 Mar 2025
Zotizalkib
CAS:2648641-36-3
TPX-0131: potent, selective, CNS-ready, oral ALK inhibitor (WT IC50: 1.4nM, G1202R/L1196M IC50: 0.3nM) with robust …
Formula:
C21H20F3N5O3
Color and Shape:
Solid
Molecular weight:
447.41
Ref: TM-T9414
| 25mg | 1,085.00 € | ||
| 50mg | 1,413.00 € | ||
| 100mg | 2,041.00 € |
Estimated delivery in United States, on Friday 7 Mar 2025
AZ12601011
CAS:2748337-86-0
AZ12601011 is a TGFBR1 kinase inhibitor that inhibits the growth of breast tumors.
Formula:
C19H15N5
Purity:
98.81%
Color and Shape:
Solid
Molecular weight:
313.36
Ref: TM-T10426
| 1mg | 97.00 € | ||
| 5mg | 231.00 € | ||
| 10mg | 370.00 € | ||
| 25mg | 716.00 € | ||
| 50mg | 1,074.00 € | ||
| 100mg | 1,484.00 € | ||
| 1mL*10mM (DMSO) | 254.00 € |
Estimated delivery in United States, on Friday 7 Mar 2025
